Skip to Main content Skip to Navigation
Journal articles

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

Abstract : Background: The role of the gut microbiota in Crohn's disease (CD) is established and fecal microbiota transplantation (FMT) is an attractive therapeutic strategy. No randomized controlled clinical trial results are available. We performed a randomized, single-blind, sham-controlled pilot trial of FMT in adults with colonic or ileocolonic CD. Method: Patients enrolled while in flare received oral corticosteroid. Once in clinical remission, patients were randomized to receive either FMT or sham transplantation during a colonoscopy. Corticosteroids were tapered and a second colonoscopy was performed at week 6. The primary endpoint was the implantation of the donor microbiota at week 6 (Sorensen index > 0.6). Results: Eight patients received FMT and nine sham transplantation. None of the patients reached the primary endpoint. The steroid-free clinical remission rate at 10 and 24 weeks was 44.4% (4/9) and 33.3% (3/9) in the sham transplantation group and 87.5% (7/8) and 50.0% (4/8; one patient loss of follow-up while in remission at week 12 and considered in flare at week 24) in the FMT group. Crohn's Disease Endoscopic Index of Severity decreased 6 weeks after FMT (p = 0.03) but not after sham transplantation (p = 0.8). Conversely, the CRP level increased 6 weeks after sham transplantation (p = 0.008) but not after FMT (p = 0.5). Absence of donor microbiota engraftment was associated with flare. No safety signal was identified. Conclusion: The primary endpoint was not reached for any patient. In this pilot study, higher colonization by donor microbiota was associated with maintenance of remission. These results must be confirmed in larger studies (NCT02097797).
Document type :
Journal articles
Complete list of metadata

https://hal.sorbonne-universite.fr/hal-03031236
Contributor : Nadège Brunel <>
Submitted on : Monday, November 30, 2020 - 1:50:50 PM
Last modification on : Thursday, May 6, 2021 - 10:51:48 AM
Long-term archiving on: : Monday, March 1, 2021 - 7:05:03 PM

File

40168_2020_Article_792.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Harry Sokol, Cecilia Landman, Philippe Seksik, Laurence Berard, Mélissa Montil, et al.. Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study. Microbiome, BioMed Central, 2020, 8 (12), ⟨10.1186/s40168-020-0792-5⟩. ⟨hal-03031236⟩

Share

Metrics

Record views

109

Files downloads

40